Conformis, Inc. Announces 510(k) Clearance for Identity Imprint™ Knee Replacement System
May 10, 2021 07:30 ET
|
Conformis, Inc.
BILLERICA, Mass., May 10, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) today announced 510(k) clearance by the U.S. Food and Drug Administration for the Company’s Identity Imprint Knee...
Conformis Reports First Quarter 2021 Financial Results
May 05, 2021 16:05 ET
|
Conformis, Inc.
BILLERICA, Mass., May 05, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today...
Conformis Announces Achievement of Third Milestone Under Development and License Agreements
April 22, 2021 16:30 ET
|
Conformis, Inc.
BILLERICA, Mass., April 22, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that it received 510(k) clearance by the U.S. Food and Drug Administration for patient-specific...
Conformis Announces License Agreement with Paragon 28
April 19, 2021 16:30 ET
|
Conformis, Inc.
BILLERICA, Mass., April 19, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that it has entered into a license agreement with Paragon 28, Inc., granting Paragon 28 a...
Global Orthopedic Devices Market 2021-2025 - Priority of Elective Surgeries in Post-COVID-19 World to Spur Demand
April 15, 2021 06:53 ET
|
Research and Markets
Dublin, April 15, 2021 (GLOBE NEWSWIRE) -- The "Orthopedic Devices Market - Global Industry Analysis (2017 - 2020), Growth Trends and Market Forecast (2021 - 2025)" report has been added to...
Conformis, Inc. to Release First Quarter 2021 Financial Results on May 5, 2021
April 07, 2021 07:30 ET
|
Conformis, Inc.
BILLERICA, Mass., April 07, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today that it will release its financial results for the first quarter ended March 31, 2021 after the...
Elective Procedures in Western Europe 2020-2023: COVID-19 Impact in Western European Nations
April 06, 2021 08:38 ET
|
Research and Markets
Dublin, April 06, 2021 (GLOBE NEWSWIRE) -- The "Impact of COVID-19 on Elective Procedures in Western Europe, 2020-2023" report has been added to ResearchAndMarkets.com's offering. The deferral of...
Conformis, Inc. Announces Clearance in Australia for iTotal® PS, the Only Personalized, Posterior-Stabilized Total Knee Replacement System
March 01, 2021 17:45 ET
|
Conformis, Inc.
BILLERICA, Mass., March 01, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) today announced the clearance of its patient-specific iTotal® PS total knee replacement system by the Therapeutic...
Conformis, Inc. Announces Pricing of $85 Million Underwritten Offering of Common Stock
February 12, 2021 08:30 ET
|
Conformis, Inc.
BILLERICA, Mass., Feb. 12, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (Nasdaq: CFMS) today announced it has priced an underwritten public offering of 80,952,381 shares of its common stock at an...
Conformis, Inc. Announces Proposed Public Offering of Common Stock
February 11, 2021 16:01 ET
|
Conformis, Inc.
BILLERICA, Mass., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (Nasdaq: CFMS) today announced that it intends to offer shares of its common stock in an underwritten public offering. Conformis...